MHRA Backs Higher-Dose Wegovy After 20% Weight Loss



UK regulators have cleared a 7.2-mg dose of semaglutide after trials showed that more than 1 in 5 patients achieved over 20% weight loss.
Medscape News UK



Source link : https://www.medscape.com/viewarticle/mhra-backs-higher-dose-wegovy-after-20-weight-loss-2026a10001lq?src=rss

Author :

Publish date : 2026-01-16 18:14:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version